Friday, November 21, 2025 7:54:44 PM
Thanks for the heads up. Now it raises a pretty big question cause the company
says they have a lot of cash on hand, and just upped their allowance for a share buyback.
So WHY would they authorize more shares.. Interesting because I have said for a while,
only having 11 Mil shares in the float is pretty frigging small when a company is on the verge
of commencing sales/revenues/profits. And its likely to give the big boys on wall street
a reason to want shares. So what are they up to? Hmmm
https://fastercapital.com/content/Stock-split--Authorized-Stock-and-Stock-Split--A-Comprehensive-Guide.html
When a company decides to split its stock, there are several important factors to consider. One of the most significant is the role of authorized stock in the process. Authorized stock refers to the maximum number of shares a company is allowed to issue, which is determined by its charter or articles of incorporation. In this section, we will explore the various ways authorized stock can impact a stock split and what companies should consider when making decisions about this important factor.
1. Understanding authorized stock
Before delving into the role of authorized stock in a stock split, it is essential to understand what it represents. authorized stock is the maximum number of shares a company can issue, as specified in its charter or articles of incorporation. This number is not always equal to the number of shares the company has actually issued or outstanding. Instead, it provides a cap on how many shares can be issued in the future.
2. impact of authorized stock on stock split
When a company decides to split its stock, it must consider how the split will affect its authorized stock. If the split will cause the number of outstanding shares to exceed the authorized stock limit, the company will need to increase its authorized stock. This can be done through a vote of the company's board of directors and shareholders.
3. Options for increasing authorized stock
There are several ways a company can increase its authorized stock. One option is to amend its charter or articles of incorporation to increase the authorized stock limit. Another option is to issue new shares through a secondary offering or private placement. However, these options can be costly and time-consuming, so companies should carefully consider the best approach for their needs.
4. Benefits of increasing authorized stock
Increasing authorized stock can provide several benefits for a company. For example, it allows the company to issue additional shares in the future, which can be used for stock splits, mergers and acquisitions, and other strategic initiatives. It also provides flexibility in case the company needs to raise additional capital quickly.
says they have a lot of cash on hand, and just upped their allowance for a share buyback.
So WHY would they authorize more shares.. Interesting because I have said for a while,
only having 11 Mil shares in the float is pretty frigging small when a company is on the verge
of commencing sales/revenues/profits. And its likely to give the big boys on wall street
a reason to want shares. So what are they up to? Hmmm
https://fastercapital.com/content/Stock-split--Authorized-Stock-and-Stock-Split--A-Comprehensive-Guide.html
When a company decides to split its stock, there are several important factors to consider. One of the most significant is the role of authorized stock in the process. Authorized stock refers to the maximum number of shares a company is allowed to issue, which is determined by its charter or articles of incorporation. In this section, we will explore the various ways authorized stock can impact a stock split and what companies should consider when making decisions about this important factor.
1. Understanding authorized stock
Before delving into the role of authorized stock in a stock split, it is essential to understand what it represents. authorized stock is the maximum number of shares a company can issue, as specified in its charter or articles of incorporation. This number is not always equal to the number of shares the company has actually issued or outstanding. Instead, it provides a cap on how many shares can be issued in the future.
2. impact of authorized stock on stock split
When a company decides to split its stock, it must consider how the split will affect its authorized stock. If the split will cause the number of outstanding shares to exceed the authorized stock limit, the company will need to increase its authorized stock. This can be done through a vote of the company's board of directors and shareholders.
3. Options for increasing authorized stock
There are several ways a company can increase its authorized stock. One option is to amend its charter or articles of incorporation to increase the authorized stock limit. Another option is to issue new shares through a secondary offering or private placement. However, these options can be costly and time-consuming, so companies should carefully consider the best approach for their needs.
4. Benefits of increasing authorized stock
Increasing authorized stock can provide several benefits for a company. For example, it allows the company to issue additional shares in the future, which can be used for stock splits, mergers and acquisitions, and other strategic initiatives. It also provides flexibility in case the company needs to raise additional capital quickly.
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:05:34 AM
- Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 • GlobeNewswire Inc. • 03/31/2026 11:00:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/30/2026 12:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:00:28 AM
- Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain • GlobeNewswire Inc. • 03/26/2026 11:00:00 AM
- Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 • GlobeNewswire Inc. • 03/23/2026 08:32:42 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/20/2026 09:12:47 PM
- Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 • GlobeNewswire Inc. • 03/18/2026 08:58:49 PM
- Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:35:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 10:01:04 AM
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights • GlobeNewswire Inc. • 03/12/2026 09:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 09:29:52 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 12:05:34 PM
- Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting • GlobeNewswire Inc. • 03/09/2026 08:30:00 PM
- Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development • GlobeNewswire Inc. • 03/05/2026 09:15:00 PM
- Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting • GlobeNewswire Inc. • 03/03/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 11:05:34 AM
- Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market • GlobeNewswire Inc. • 03/03/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:03:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:03:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:02:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:01:33 PM
